Saurabh Saha - 31 Dec 2024 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Executive Officer, Director
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
31 Dec 2024
Net transactions value
-$592,900
Form type
4
Filing time
31 Dec 2024, 16:31:22 UTC
Previous filing
20 Dec 2024
Next filing
22 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $592,900 -36,263 -7% $16.35 484,398 31 Dec 2024 Direct F1, F2
holding CNTA Ordinary Shares 38,000 31 Dec 2024 By trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3 These shares are held directly in a trust, for which the Reporting Person and his spouse serve as trustees.